Stem cells

An overview of the current status of therapies for central and peripheral nervous system diseases

A. Orlacchio, G. Bernardi, A. Orlacchio, S. Martino

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

In regenerative medicine, stem cells are currently considered ideal candidates for the treatment of diseases and injuries of the nervous system, for which, at present, there are no effective treatments. Promising results have been shown by clinical trials for neurodegenerative diseases such as Parkinson's diseases, but also for demyelinising disorders and traumatic lesions of the brain and spinal cord. The proof-of-principle is that the replacement of damaged cells and the restoration of function can be accomplished by the transplantation of embryonic or adult stem cells. Advancements in stem cell biology were recently propelled by the ability to generate induced pluripotent stem (iPS) cells from fibroblasts of several neurodegenerative diseases (e.g. Parkinson's and Huntington's diseases, Amyotrophic Lateral Sclerosis and Spinal Muscular Atrophy). In this review, we discuss the molecular basis of stem cell therapy and the advancement of research on regenerative medicine for diseases and injuries of the nervous system.

Original languageEnglish
Pages (from-to)595-608
Number of pages14
JournalCurrent Medicinal Chemistry
Volume17
Issue number7
DOIs
Publication statusPublished - Mar 2010

Fingerprint

Central Nervous System Diseases
Neurology
Peripheral Nervous System Diseases
Stem cells
Nervous System Trauma
Regenerative Medicine
Stem Cells
Nervous System Diseases
Neurodegenerative Diseases
Parkinson Disease
Neurodegenerative diseases
Spinal Muscular Atrophy
Induced Pluripotent Stem Cells
Adult Stem Cells
Aptitude
Huntington Disease
Amyotrophic Lateral Sclerosis
Embryonic Stem Cells
Cell- and Tissue-Based Therapy
Cell Biology

Keywords

  • Adult stem cells
  • Central and peripheral nervous system diseases
  • Embryonic stem cells
  • Induced pluripotent stem cells
  • Stem cell therapy

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Cite this

Stem cells : An overview of the current status of therapies for central and peripheral nervous system diseases. / Orlacchio, A.; Bernardi, G.; Orlacchio, A.; Martino, S.

In: Current Medicinal Chemistry, Vol. 17, No. 7, 03.2010, p. 595-608.

Research output: Contribution to journalArticle

@article{154cc130bbbc4aeea498aefe35413dc9,
title = "Stem cells: An overview of the current status of therapies for central and peripheral nervous system diseases",
abstract = "In regenerative medicine, stem cells are currently considered ideal candidates for the treatment of diseases and injuries of the nervous system, for which, at present, there are no effective treatments. Promising results have been shown by clinical trials for neurodegenerative diseases such as Parkinson's diseases, but also for demyelinising disorders and traumatic lesions of the brain and spinal cord. The proof-of-principle is that the replacement of damaged cells and the restoration of function can be accomplished by the transplantation of embryonic or adult stem cells. Advancements in stem cell biology were recently propelled by the ability to generate induced pluripotent stem (iPS) cells from fibroblasts of several neurodegenerative diseases (e.g. Parkinson's and Huntington's diseases, Amyotrophic Lateral Sclerosis and Spinal Muscular Atrophy). In this review, we discuss the molecular basis of stem cell therapy and the advancement of research on regenerative medicine for diseases and injuries of the nervous system.",
keywords = "Adult stem cells, Central and peripheral nervous system diseases, Embryonic stem cells, Induced pluripotent stem cells, Stem cell therapy",
author = "A. Orlacchio and G. Bernardi and A. Orlacchio and S. Martino",
year = "2010",
month = "3",
doi = "10.2174/092986710790416272",
language = "English",
volume = "17",
pages = "595--608",
journal = "Current Medicinal Chemistry",
issn = "0929-8673",
publisher = "Bentham Science Publishers B.V.",
number = "7",

}

TY - JOUR

T1 - Stem cells

T2 - An overview of the current status of therapies for central and peripheral nervous system diseases

AU - Orlacchio, A.

AU - Bernardi, G.

AU - Orlacchio, A.

AU - Martino, S.

PY - 2010/3

Y1 - 2010/3

N2 - In regenerative medicine, stem cells are currently considered ideal candidates for the treatment of diseases and injuries of the nervous system, for which, at present, there are no effective treatments. Promising results have been shown by clinical trials for neurodegenerative diseases such as Parkinson's diseases, but also for demyelinising disorders and traumatic lesions of the brain and spinal cord. The proof-of-principle is that the replacement of damaged cells and the restoration of function can be accomplished by the transplantation of embryonic or adult stem cells. Advancements in stem cell biology were recently propelled by the ability to generate induced pluripotent stem (iPS) cells from fibroblasts of several neurodegenerative diseases (e.g. Parkinson's and Huntington's diseases, Amyotrophic Lateral Sclerosis and Spinal Muscular Atrophy). In this review, we discuss the molecular basis of stem cell therapy and the advancement of research on regenerative medicine for diseases and injuries of the nervous system.

AB - In regenerative medicine, stem cells are currently considered ideal candidates for the treatment of diseases and injuries of the nervous system, for which, at present, there are no effective treatments. Promising results have been shown by clinical trials for neurodegenerative diseases such as Parkinson's diseases, but also for demyelinising disorders and traumatic lesions of the brain and spinal cord. The proof-of-principle is that the replacement of damaged cells and the restoration of function can be accomplished by the transplantation of embryonic or adult stem cells. Advancements in stem cell biology were recently propelled by the ability to generate induced pluripotent stem (iPS) cells from fibroblasts of several neurodegenerative diseases (e.g. Parkinson's and Huntington's diseases, Amyotrophic Lateral Sclerosis and Spinal Muscular Atrophy). In this review, we discuss the molecular basis of stem cell therapy and the advancement of research on regenerative medicine for diseases and injuries of the nervous system.

KW - Adult stem cells

KW - Central and peripheral nervous system diseases

KW - Embryonic stem cells

KW - Induced pluripotent stem cells

KW - Stem cell therapy

UR - http://www.scopus.com/inward/record.url?scp=77950653264&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950653264&partnerID=8YFLogxK

U2 - 10.2174/092986710790416272

DO - 10.2174/092986710790416272

M3 - Article

VL - 17

SP - 595

EP - 608

JO - Current Medicinal Chemistry

JF - Current Medicinal Chemistry

SN - 0929-8673

IS - 7

ER -